Abstract
Social multipliers occur when individuals’ actions influence other individuals’ actions so as to lead to amplified aggregate effects. Epidemic infections offer a dramatic example of this phenomenon since individual actions such as social distancing and masking that have small effects on individual risk can have very large effects in reducing rates of infection when they are widely adopted. This paper uses the info-metric method of constrained maximum entropy modeling to estimate the impact of social multiplier effects in the Covid-19 epidemic with a model that infers the length of infection, the rate of mortality, the base infection factor, and reductions in the infection factor due to changes in social behavior from data on daily infections and deaths. When the model takes account of the rate of reporting of infections, it produces two scenarios of epidemic dynamics: one in which reporting is low, under 10%, the estimated infection is correspondingly large, and immunity effects play a significant role in stabilizing the epidemic; and a second where reporting rates are close to 100%, and the epidemic is controlled mostly by changes in social behavior.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
No clinical research.
Funding Statement
No external support.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB approval required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
I’d like to thank Amos Golan, David A. Oliver, and Nicholas C. Foley for conversations concerning the logic of this model, methods, and important features of the disease. Comments from the BiosecurityAnalysis Seminar contributed greatly to revision of the original draft.
Link to the Mathematica notebook documenting the methods has been added. A parameter representing the rate at which infections are reported as confirmed has been added to the model: estimates of this parameter can have significant qualitative impact on the simulations, including an increased role of immunity in controlling epidemics and the estimation of significant initial levels of population immunity to the infection. Slides reporting updated model estimates of the Covid epidemic have been added.
Data Availability
Data is publicly available from sources cited in the paper.
